ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,034,670 | -10.4% | 535,363 | -14.1% | 0.00% | 0.0% |
Q2 2023 | $7,849,586 | -7.3% | 622,983 | -4.0% | 0.00% | -33.3% |
Q1 2023 | $8,464,530 | -14.8% | 648,623 | +15.2% | 0.00% | 0.0% |
Q4 2022 | $9,934,000 | +10.8% | 563,102 | -4.4% | 0.00% | 0.0% |
Q3 2022 | $8,969,000 | +22.8% | 588,886 | +19.6% | 0.00% | 0.0% |
Q2 2022 | $7,303,000 | -42.5% | 492,449 | -12.8% | 0.00% | -25.0% |
Q1 2022 | $12,711,000 | +31.3% | 564,456 | +7.6% | 0.00% | +33.3% |
Q4 2021 | $9,678,000 | +37.6% | 524,442 | -0.3% | 0.00% | +50.0% |
Q3 2021 | $7,035,000 | -38.6% | 526,214 | -15.0% | 0.00% | -50.0% |
Q2 2021 | $11,455,000 | +13.0% | 618,902 | -8.3% | 0.00% | +33.3% |
Q1 2021 | $10,137,000 | -11.2% | 675,139 | -14.6% | 0.00% | -25.0% |
Q4 2020 | $11,412,000 | +40.1% | 790,224 | -21.0% | 0.00% | +33.3% |
Q3 2020 | $8,144,000 | +19.4% | 1,000,534 | -0.7% | 0.00% | 0.0% |
Q2 2020 | $6,821,000 | +68.5% | 1,007,313 | +75.2% | 0.00% | +50.0% |
Q1 2020 | $4,047,000 | -25.4% | 574,800 | +4.1% | 0.00% | 0.0% |
Q4 2019 | $5,423,000 | -11.2% | 552,403 | -0.7% | 0.00% | -33.3% |
Q3 2019 | $6,109,000 | -2.1% | 556,471 | +3.7% | 0.00% | 0.0% |
Q2 2019 | $6,242,000 | +14.6% | 536,732 | -6.0% | 0.00% | 0.0% |
Q1 2019 | $5,446,000 | -49.9% | 570,958 | -49.3% | 0.00% | -40.0% |
Q4 2018 | $10,863,000 | -33.9% | 1,126,909 | -2.3% | 0.01% | -16.7% |
Q3 2018 | $16,443,000 | +29.4% | 1,153,951 | +8.9% | 0.01% | 0.0% |
Q2 2018 | $12,712,000 | -10.6% | 1,059,242 | -8.0% | 0.01% | 0.0% |
Q1 2018 | $14,223,000 | -14.1% | 1,151,700 | +1.2% | 0.01% | -25.0% |
Q4 2017 | $16,553,000 | +22.1% | 1,137,635 | +19.4% | 0.01% | +33.3% |
Q3 2017 | $13,559,000 | +106.9% | 952,925 | +85.6% | 0.01% | +100.0% |
Q2 2017 | $6,552,000 | +7.7% | 513,436 | +7.0% | 0.00% | 0.0% |
Q1 2017 | $6,082,000 | +25.6% | 479,719 | +1.2% | 0.00% | 0.0% |
Q4 2016 | $4,842,000 | -21.3% | 474,133 | +1.5% | 0.00% | 0.0% |
Q3 2016 | $6,150,000 | +5.3% | 467,041 | +1.6% | 0.00% | 0.0% |
Q2 2016 | $5,838,000 | -1.6% | 459,680 | +2.3% | 0.00% | -25.0% |
Q1 2016 | $5,935,000 | -14.2% | 449,220 | -0.2% | 0.00% | 0.0% |
Q4 2015 | $6,921,000 | +21.8% | 450,054 | -1.8% | 0.00% | 0.0% |
Q3 2015 | $5,682,000 | -28.9% | 458,241 | -21.5% | 0.00% | -20.0% |
Q2 2015 | $7,990,000 | +16.0% | 584,018 | +1.4% | 0.01% | +25.0% |
Q1 2015 | $6,888,000 | -4.4% | 575,937 | +2.1% | 0.00% | 0.0% |
Q4 2014 | $7,202,000 | -38.7% | 563,920 | -35.6% | 0.00% | -42.9% |
Q3 2014 | $11,749,000 | -37.2% | 875,783 | -24.9% | 0.01% | -36.4% |
Q2 2014 | $18,720,000 | -19.2% | 1,166,310 | -9.2% | 0.01% | -21.4% |
Q1 2014 | $23,155,000 | -20.1% | 1,284,268 | -31.5% | 0.01% | -22.2% |
Q4 2013 | $28,990,000 | -8.5% | 1,875,155 | -12.0% | 0.02% | -14.3% |
Q3 2013 | $31,686,000 | +78.5% | 2,130,980 | +55.3% | 0.02% | +75.0% |
Q2 2013 | $17,756,000 | – | 1,372,154 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |